Inteliview
Log inSign up
IPO Tracker
O

Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

US / NASDAQ CapitalRumored
Valuation$274M
Expected2026-05-08
Sector--
IPO Price$17
RELATED IPOS
C
CCIS Acquisition CorpCCIS Acquisition CorpSPAC · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
First Breach, Inc.
First Breach, Inc.First Breach, Inc.US · --
E
EUPEC International Group LtdEUPEC International Group LtdUS · --
L
Lakewood-Amedex Biotherapeutics Inc.Lakewood-Amedex Biotherapeutics Inc.N/A · --
FAQ

When is the Odyssey Therapeutics, Inc. IPO expected?

The Odyssey Therapeutics, Inc. IPO is currently in the Rumored stage. The expected timeline is 2026-05-08. Timelines may change based on market conditions.

What is Odyssey Therapeutics, Inc.'s valuation?

Odyssey Therapeutics, Inc.'s estimated valuation is approximately $274M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Odyssey Therapeutics, Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NASDAQ Capital after listing. Some brokerages offer IPO access programs for pre-IPO allocation.